SK

Sandeep Kumar Tiwari

Active Director Director DIN 10158350
DIN 10158350 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sandeep Kumar Tiwari

Data last updated:

Sandeep Kumar Tiwari is a Director at Sandy Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10158350
Primary Designation Director
Industry Pharma
First Appointment 11 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sandy Pharmaceutical Private Limited U47721MH2023PTC402709
Director11 May 20232023Active

Board colleagues of Sandeep Kumar Tiwari

NameDINCompanyDesignation
Savita Tiwari10158349Sandy Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sandy Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sandeep Kumar Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandeep Kumar Tiwari

Sandeep Kumar Tiwari currently holds 1 directorship: Sandy Pharmaceutical Private Limited (Director, since 11 May 2023).

Sandeep Kumar Tiwari was first appointed on 11 May 2023 as Director at Sandy Pharmaceutical Private Limited.

The current boards of Sandeep Kumar Tiwari's companies include Savita Tiwari (Sandy Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available